Stereotaxis, Inc.
AMEX:STXSMedical - Instruments & Supplies
+$0.05 today
- Market cap
- $94.80M
- Beta
- 1.32
- P/E (TTM)
- -8.3
- EPS (TTM)
- -$0.22
Volume 0.90M
Average 0.39M
STXS Other Income / Expenses
Net non-operating gains and losses, such as investment results, currency effects, and one-off items.
Stereotaxis, Inc.AMEX: STXS
Other Income / Expenses · Q1 FY2026 · quarter ended Mar 2026
Other income / expenses turns negative
Q1 FY2026 other income / expenses was -$680K, compared with $106K a year earlier. Trailing-twelve-month other income / expenses was -$317K. Over 3 fiscal years it compounded at -1.0% a year.
Context
- Other income / expenses amounted to 1.4% of revenue in FY2025, down 1.1 pp from a year earlier.
- Other income / expenses increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly other income / expenses holds near -$680K or moves back toward the trailing-twelve-month quarterly average of -$79.25K.
Sources:Income StatementText generated from reported figures; not investment advice.
Other Income / Expenses history
USD · from the income statement
- Latest · FY2025
- 469K USD
- Year-over-year change
- -32.4%
- 4-year CAGR
- -31.8%
| Period | Period end | Other Income / Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 469K | -32.4% |
| FY2024 | 2024-12-31 | 694K | -38.4% |
| FY2023 | 2023-12-31 | 1.13M | +132.6% |
| FY2022 | 2022-12-31 | 484K | -77.7% |
| FY2021 | 2021-12-31 | 2.17M | — |
Other Income / Expenses vs competitors
How STXS compares with its peers on the latest reported figures
- STXS's LTM Mar 2026 other income / expenses of -$317K is the 3rd highest of the 5 companies compared; the peer median is -$1.16M.
- Its year-over-year change of -156.5% is the 4th highest of 5, against a peer median of +8.2%.
- Other income / expenses amounts to 1.0% of revenue for STXS, versus a peer median of 5.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $1.83M | +210.7% | +142.0% | 1742.9% | |
| LTM Mar 2026 | $218.28K | +3.2% | -24.8% | 0.5% | |
| LTM Mar 2026 | -$317K | -156.5% | -1.0% | 1.0% | |
| LTM Mar 2026 | -$2.54M | -381.8% | — | 6.3% | |
| LTM Mar 2026 | -$4.81M | +13.1% | — | 4.8% | |
| Peer median (excluding STXS) | -$1.16M | +8.2% | +58.6% | 5.5% | |
Competitors are the stored peer set for STXS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 35.02M | 28.15M | 26.77M | 26.92M | 32.38M |
| Cost of Revenue | 11.79M | 9.68M | 11.91M | 12.32M | 15.31M |
| Gross Profit | 23.23M | 18.47M | 14.86M | 14.59M | 17.07M |
| Gross Margin | 66.3% | 65.6% | 55.5% | 54.2% | 52.7% |
| Research & Development | 10.2M | 10.56M | 10.27M | 9.76M | 9.38M |
| Selling, General & Admin | 25.92M | 26.69M | 26.43M | 29.57M | 30.29M |
| Operating Expenses | 36.12M | 37.25M | 36.7M | 39.33M | 39.18M |
| Depreciation & Amortization | 106K | 429K | 595K | 969K | 1.56M |
| EBITDA | (10.6M) | (17.86M) | (20.12M) | (23.08M) | (20.09M) |
| EBITDA Margin | -30.3% | -63.5% | -75.1% | -85.7% | -62.0% |
| Operating Income | (12.89M) | (18.78M) | (21.84M) | (24.74M) | (22.11M) |
| Operating Margin | -36.8% | -66.7% | -81.6% | -91.9% | -68.3% |
| Interest Income | 0 | 484K | 1.1M | 694K | 467K |
| Interest Expense | 10.07K | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 2.17M | 484K | 1.13M | 694K | 469K |
| Income Before Tax | (10.72M) | (18.29M) | (20.71M) | (24.05M) | (21.64M) |
| Pre-Tax Margin | -30.6% | -65.0% | -77.4% | -89.3% | -66.8% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (10.72M) | (18.29M) | (20.71M) | (24.05M) | (21.64M) |
| Net Margin | -30.6% | -65.0% | -77.4% | -89.3% | -66.8% |
| EPS (Basic) | (0.16) | (0.26) | (0.27) | (0.30) | (0.25) |
| EPS (Diluted) | (0.16) | (0.26) | (0.27) | (0.30) | (0.25) |
| Weighted Avg Shares | 75.56M | 76.06M | 80.7M | 85.18M | 90.96M |
| Weighted Avg Shares (Diluted) | 75.56M | 76.06M | 80.7M | 85.18M | 90.96M |
Stereotaxis, Inc.
AMEX:STXS
Intrinsic Alpha fair value
Locked
Current Price
$0.95
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.